Advertisement

Topics

Sosei Co. Ltd Company Profile

18:23 EDT 21st September 2018 | BioPortfolio

Sosei Co. Ltd. is a global biopharmaceutical company with significant expertise in product discovery and development. It has established a reduced risk business model primarily upon identifying new uses for established drugs and exploiting its unique position within Japanese, European and North American pharmaceutical markets by acquiring compounds from, and bringing compounds into, Japan.

The company has a strong product discovery, clinical development and commercialisation team based in UK and Tokyo and supported by an international board of directors and a scientific advisory board.

Location

4F Ichiban-cho FS Bldg.8 Ichiban-cho Chiyoda-ku
TOKYO
102-0082
Japan

Contact

Phone: 81-(0)3-5210-3290
Fax: 81-(0)3-5210-3291


News Articles [34 Associated News Articles listed on BioPortfolio]

Sosei Collaboration with PeptiDream Progressing Well

TOKYO and LONDON, May 24, 2018 /PRNewswire/ -- Peptide antagonists with high affinity and selectivity against PAR2 target identified Sosei Group Corporation ("Sosei" or the "Company"; TSE Mothers ...

Sosei shares tank after safety issue with Alzheimer's drug

Allergan and Sosei’s experimental Alzheimer’s medicine has run into trouble – the companies have called a halt to trials after an unexpected toxicology finding in an animal study. Japan-based S...

The story of how UK Biotech Heptares drives its clinical program after its acquisition by Sosei

Heptares is a leading UK biotech that was bought earlier this year for up to $400 million by the Japanese company, Sosei Group Corporation. Malcolm Weir, CEO and Founder of Heptares, talks to Fintan ...

Teva Ends Collaboration, Returns Clinic-Bound GPCR Candidate to Sosei

Teva Pharmaceutical Industries has ended a 2-1/2 year, up-to-$410 million-plus collaboration with Sosei Group’s Heptares Therapeutics subsidiary to develop and commercialize Heptares’ lead candida...

Allergan and Sosei Halt Alzheimer’s Trial Over Safety Concerns

Allergan and its development partner Sosei Group have voluntarily suspended clinical trials of HTL0018318 in Alzheimer’s and other types of dementia because of safety problems.

Allergan, Sosei suspend clinical development of dementia drug

Allergan and Sosei are voluntarily suspending clinical development activities with HTL0018318 pending investigation of an unexpected toxicology finding in an animal study involving non-human primates.

Sosei Regains Worldwide Rights from Teva to Develop and Commercialize ...

Sosei Regains Worldwide Rights from Teva to Develop and Commercialize Novel Small Molecule CGRP Antagonists for Migraine and Other Severe Headaches Sosei Group , the world leader in GPCR medicine desi...

Sosei see Teva pipeline cull as an opportunity

Troubled generics giant Teva is continuing the heavy pruning of its business and has cut a novel migraine drug from its pipeline. Sosei and its UK-based Heptares division have lost a partner because...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Sosei Group Corporation

Sosei is an international biopharmaceutical company anchored in Japan with a global reach. It practises a reduced risk business model by acquiring compounds from, and bringing com...

Sosei Co. Ltd

Sosei Co. Ltd. is a global biopharmaceutical company with significant expertise in product discovery and development. It has established a reduced risk business model primarily upon identifying new us...

More Information about "Sosei Co. Ltd" on BioPortfolio

We have published hundreds of Sosei Co. Ltd news stories on BioPortfolio along with dozens of Sosei Co. Ltd Clinical Trials and PubMed Articles about Sosei Co. Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sosei Co. Ltd Companies in our database. You can also find out about relevant Sosei Co. Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record